Physician profile
Amit Haresh Patel
NPI 1346515756
$1,383.14
in general payments reported to CMS, 2019-2025
17 companies · $20.38 in 2025
The $20.38 reported for 2025 was less than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $463 · 2020: $170 · 2021: $378 · 2022: $287 · 2023: $50.02 · 2024: $14.00 · 2025: $20.38.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $84.40.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $84.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $264.99 | 2019-2022 | |
| Novo Nordisk INC | $250.00 | 2020-2021 | |
| Actelion Pharmaceuticals US, INC. | $216.81 | 2019-2021 | |
| Glaxosmithkline, LLC. | $106.10 | 2019-2024 | Trelegy Ellipta, Arexvy, Shingrix |
| Astrazeneca Pharmaceuticals LP | $90.23 | 2019-2022 | |
| Allergan, INC. | $86.80 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $81.97 | 2019 | |
| La Jolla Pharmaceutical Company | $63.29 | 2021 | |
| Amgen INC. | $57.93 | 2021-2023 | Tezspire |
| Sunovion Pharmaceuticals INC. | $28.88 | 2019 | |
| Abbvie INC. | $28.44 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $25.32 | 2019-2021 | |
| Pharmacosmos Therapeutics INC. | $20.38 | 2025 | Monoferric |
| Sumitomo Pharma America, INC. | $19.65 | 2023 | Gemtesa |
| Mylan Specialty L.P. | $18.05 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $13.01 | 2022 | |
| Paratek Pharmaceuticals, INC. | $11.29 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amit Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.